Table 2 Utilization of healthcare among patients with metastatic lung cancer receiving chemotherapy
From: Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
| Â | Value | |
|---|---|---|
| Â | n = 4068 | |
Inpatient, mean | Â | Â |
   Acute hospital |  |  |
Admissions (#) | 1.5 | |
Days (#) | 8.9 | |
Outpatient Services, mean | Â | Â |
   Physician Office (#) | 41.5 | |
   Emergency Room (#) | 1.6 | |
   Hospital Outpatient (#) | 18.2 | |
   Home Health (#) | 4.7 | |
   Other (#) | 10.1 | |
Pharmacy Prescriptions (#), mean | 39.7 | |
Inpatient, n (%) | Â | Â |
   Acute hospital | 2,933 | (72.1%) |
Outpatient Services*, n (%) | Â | Â |
   Emergency Room | 2,532 | (62.2%) |
   Physician Office/Hospital Outpatient |  |  |
Evaluation and Management | 3,947 | (97.0%) |
Laboratory | 3,331 | (81.9%) |
Radiology Diagnostic | 3,691 | (90.7%) |
Radiology Therapeutic | 2,241 | (55.1%) |
Nuclear Medicine | 1,826 | (44.9%) |
Anesthesia and invasive procedures | 2,581 | (63.4%) |
Blood & Transfusion | 338 | (8.3%) |
Physical & Occupational Therapy | 402 | (9.9%) |
Medical & Surgical Supplies | 2,104 | (51.7%) |
Mental health-care | 2,772 | (68.1%) |
Other | 134 | (3.3%) |
Chemo administration | 3,943 | (96.9%) |
Subtotal | 4,032 | (99.1%) |
   Home Health/Hospice/Skilled Nursing | 2,200 | (54.1%) |
   Other | 3,314 | (81.5%) |
   Total | 4,053 | (99.6%) |
Medication, n (%) | Â | Â |
   Chemotherapy | 4,068 | (100.0%) |
   G-CSF | 1,159 | (28.5%) |
   ESAs | 1,859 | (45.7%) |
   Pain, sedatives, antidepressants | 3,629 | (89.2%) |
   Anti-infectives | 2,991 | (73.5%) |
   Anti-emetics | 3,445 | (84.7%) |
   Bisphosphonates | 721 | (17.7%) |
   Biologics | 186 | (4.6%) |
   Gastrointestinal | 2,337 | (57.4%) |
   Electrolytes, Caloric, Water | 1,981 | (48.7%) |
   Cardiovascular | 2,161 | (53.1%) |
   Blood products & Anticoagulants | 1,393 | (34.2%) |
   Other | 3,976 | (97.7%) |
Total | 4,068 | (100.0%) |
TOTAL | 4,068 | (100.0%) |